Thomas J. George

Also affiliated with University of Florida, UF Health Cancer Center, Florida College

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

6.2Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Assessing the practice of data quality evaluation in a national clinical data research network through a systematic scoping review in the era of real-world data

Journal of the American Medical Informatics Association(2020)10.1093/jamia/ocaa245

Top 7%

3.3DataRank

Top 7%95 citations

Tianchen Lyu, Alexander Loiacono, Tonatiuh Mendoza Viramontes, Gloria Lipori, Yi Guo +7 more

Papers

Driven by 77 papers — median percentile 73. Top paper: “Preoperative Treatment of Locally Advanced Rectal Cancer”.

Preoperative Treatment of Locally Advanced Rectal Cancer

New England Journal of Medicine(2023)10.1056/nejmoa2303269

N/A

5.6DataRank · unranked

460 citations

Qian Shi, Martin R. Weiser, Marc J. Gollub, Leonard B. Saltz, Benjamin Musher +20 more

Assessing the practice of data quality evaluation in a national clinical data research network through a systematic scoping review in the era of real-world data

Journal of the American Medical Informatics Association(2020)10.1093/jamia/ocaa245

Top 7%

3.3DataRank

Top 7%95 citations

Tianchen Lyu, Alexander Loiacono, Tonatiuh Mendoza Viramontes, Gloria Lipori, Yi Guo +7 more

Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification

Journal of Clinical Oncology(2022)10.1200/jco.22.00830

N/A

2.2DataRank · unranked

97 citations

Shuyang Yao, Yuan Yuan, Rebecca A. Previs, Anthony Elias, Richard D. Carvajal +15 more

Exploring the feasibility of using real-world data from a large clinical data research network to simulate clinical trials of Alzheimer’s disease

npj Digital Medicine(2021)10.1038/s41746-021-00452-1

Top 11%

1.9DataRank

Top 11%40 citations

Hansi Zhang, Yi Guo, Thomas J. George, Mattia Prosperi, William R. Hogan +5 more

Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer

BMC Cancer(2024)10.1186/s12885-024-12529-7

N/A

0.808DataRank · unranked

39 citations

Qian Shi, Arvind Dasari, Julio García‐Aguilar, Hanna Sanoff, Thomas J. George +25 more

Cancer incidence after asthma diagnosis: Evidence from a large clinical research network in the United States

Cancer Medicine(2023)10.1002/cam4.5875

Top 27%

0.737DataRank

Top 27%15 citations

Jiang Bian, Zhaoyi Chen, Jennifer N. Fishe, Dongyu Zhang, Dejana Braithwaite +4 more

A real-world cohort study of immune-related adverse events in patients receiving immune checkpoint inhibitors

npj Precision Oncology(2025)10.1038/s41698-025-01123-0

N/A

0.509DataRank · unranked

16 citations

Yi Guo, Aik Choon Tan, Lili Zhao, Xu Shi, Yong Chen +7 more

SWOG 1609 cohort 48: anti–CTLA‐4 and anti–PD‐1 for advanced gallbladder cancer

Cancer(2024)10.1002/cncr.35243

N/A

0.496DataRank · unranked

15 citations

Elizabeth Guadarrama, Young Kwang Chae, Michael J. Dennis, Benjamin Powers, Chih‐Yi Liao +9 more

A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma

Future Oncology(2023)10.2217/fon-2023-0256

N/A

0.399DataRank · unranked

4 citations

Sherise C. Rogers, Ji‐Hyun Lee, Brian Hemendra Ramnaraign, İlyas Şahin, Jesus C. Fabregas +11 more

CYP2D6 ‐guided opioid therapy for adults with cancer pain: A randomized implementation clinical trial

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy(2023)10.1002/phar.2875

N/A

0.386DataRank · unranked

5 citations

Emily J. Cicali, Alex Del Cueto, Diane Portman, Kristine A. Donovan, Yan Gong +17 more

Call to action: overcoming enrollment disparities in cancer clinical trials with modernized eligibility criteria

JNCI Cancer Spectrum(2023)10.1093/jncics/pkad009

N/A

0.385DataRank · unranked

12 citations

Devon C. Freudenberger, Kelly M. Herremans, Vignesh Vudatha, Daniel Neal, Thomas J. George +2 more

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

Obesity(2025)10.1002/oby.24366

N/A

0.383DataRank · unranked

10 citations

Hao Dai, Huilin Tang, William T. Donahoo, Thomas J. George, Ramon C. Sun +9 more

A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR

Neoplasia(2024)10.1016/j.neo.2024.101070

N/A

0.330DataRank · unranked

8 citations

Gerik W. Tushoski-Alemán, Peiyi Zhang, Guangrong Zheng, Daohong Zhou, Zhiguang Huo +6 more

Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)

BMC Cancer(2024)10.1186/s12885-024-11899-2

N/A

0.324DataRank · unranked

4 citations

Eric D. Miller, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +13 more

Proof-of-Concept of an Integrated Yoga and Psychological Intervention in Mitigating Distress Among Diverse Women With Gynecologic, Gastrointestinal, and Thoracic Cancers

Integrative Cancer Therapies(2024)10.1177/15347354241283113

N/A

0.301DataRank · unranked

5 citations

Elizabeth L. Kacel, Kelsey C. Bacharz, Adaixa Padrón Wilborn, Sonia Mesa, Halle T. McCracken +7 more

NRG-GI004/SWOG-S1610: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study—A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.tps158

N/A

0.241DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

Utilizing Patient Input in Rectal Cancer Trial Design

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf074

N/A

0.241DataRank · unranked

4 citations

Wini Zambare, Manju George, Reese Garcia, Phuong Gallagher, Caleah Kitchens +22 more

Genetic Predictors of Severe Skin Toxicity in Patients with Stage III Colon Cancer Treated with Cetuximab: NCCTG N0147 (Alliance)

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-20-1274

N/A

0.216DataRank · unranked

2 citations

Xinwei Hua, Tabitha A. Harrison, Barbara L. Banbury, Jeroen R. Huyghe, Wei Sun +13 more

Validate Real-World Data-based Endpoint Measures of Cancer Treatment Outcomes

medRxiv(2021)10.1101/2021.06.10.21258706

N/A

0.214DataRank · unranked

2 citations

Hansi Zhang, Zhaoyi Chen, Yi Guo, Thomas J. George, Yong Chen +3 more

The Impact of Race–Ethnicity and Diagnosis of Alzheimer’s Disease and Related Dementias on Mammography Use

Cancers(2022)10.3390/cancers14194726

N/A

0.208DataRank · unranked

3 citations

Yongqiu Li, Jennifer Woodard, Jessica Y. Islam, Shuang Yang, Thomas J. George +4 more

Exploring the Feasibility of Using Real-World Data from a Large Clinical Data Research Network to Simulate Clinical Trials of Alzheimer’s Disease

medRxiv(2020)10.1101/2020.06.03.20121491

Top 65%

0.208DataRank

Top 65%3 citations

Hansi Zhang, Yi Guo, Thomas J. George, Mattia Prosperi, William R. Hogan +5 more

The Burden of Cancer and Pre-cancerous Conditions Among Transgender Individuals in a Large Healthcare Network

medRxiv(2024)10.1101/2024.03.24.24304777

N/A

0.130DataRank · unranked

1 citations

Yongqiu Li, Christopher W. Wheldon, Mattia Prosperi, Thomas J. George, Elizabeth Shenkman +4 more

The Burden of Cancer and Precancerous Conditions Among Transgender Individuals in a Large Health Care Network: Retrospective Cohort Study

JMIR Cancer(2025)10.2196/73843

N/A

0.104DataRank · unranked

1 citations

Yongqiu Li, Christopher W. Wheldon, Jessica Y. Islam, Mattia Prosperi, Thomas J. George +5 more

Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3634

N/A

0.104DataRank · unranked

1 citations

Yu Guan, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Ibrahim Halil Sahin +10 more

Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)—NRG-GI004/SWOG-S1610.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps3647

N/A

0DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +11 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps233

N/A

0DataRank · unranked

3 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +8 more

Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps3643

N/A

0DataRank · unranked

3 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +9 more

Association of multiplex-immunofluorescence (m-IF) and gene expression signature with prognosis and bevacizumab (bev) treatment outcomes in NRG oncology/NSABP C-08: Implications for combining immune checkpoint blockade (ICB) and bev.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.140

N/A

0DataRank · unranked

0 citations

Marion Joy, Ying Wang, Rim S. Kim, Patrick G. Gavin, Debora Fumagalli +13 more

A point-of-care pilot randomized intervention to connect patients with cancer-induced financial toxicity to telehealth financial counseling

Cancer Causes & Control(2023)10.1007/s10552-023-01794-9

N/A

0DataRank · unranked

9 citations

Anna Maria Abi Nehme, Ji‐Hyun Lee, Derek Li, Erin M. Mobley, Julia Close +7 more

Gold Nanoparticle-Based Microfluidic Chips for Capture and Detection of Circulating Tumor Cells

Biosensors(2023)10.3390/bios13070706

N/A

0DataRank · unranked

9 citations

Kangfu Chen, Thomas J. George, Z. Hugh Fan, Valber A. Pedrosa

Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma

Journal of Cachexia Sarcopenia and Muscle(2023)10.1002/jcsm.13390

N/A

0DataRank · unranked

7 citations

Kelly M. Herremans, Vignesh Vudatha, Song Han, Xufeng Qu, Jinze Liu +8 more

Florida-California Cancer Research, Education and Engagement (CaRE 2 ) Health Equity Center: Structure, Innovations, and Initial Outcomes

Cancer Control(2023)10.1177/10732748231197878

N/A

0DataRank · unranked

5 citations

Folakemi T. Odedina, John D. Carpten, Kinfe K. Redda, Mariana C. Stern, Janice L. Krieger +51 more

Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans

Journal of the National Medical Association(2023)10.1016/j.jnma.2023.01.008

N/A

0DataRank · unranked

5 citations

David L. DeRemer, Esther Frimpong, Edward Agyare, John M. Allen, Luisel Ricks‐Santi +4 more

NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad143

N/A

0DataRank · unranked

2 citations

Rebecca C. Auer, May Cho, N.A. Dasari, Cynthia Davies-Venn, Cathy Eng +36 more

Long-term results from NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.7

N/A

0DataRank · unranked

40 citations

Greg Yothers, Osama E. Rahma, Theodore S. Hong, Marcia M. Russell, Y. Nancy You +14 more

Alliance A022104/NRG-GI010: A randomized phase II trial testing the efficacy of triplet versus doublet chemotherapy to achieve clinical complete response in patients with locally advanced rectal cancer—The Janus Rectal Cancer trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3640

N/A

0DataRank · unranked

21 citations

Arvind Dasari, Qian Shi, Julio García‐Aguilar, Hanna K. Sanoff, Thomas J. George +13 more

PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.17_suppl.lba2

N/A

0DataRank · unranked

18 citations

Qian Shi, Martin R. Weiser, Marc J. Gollub, Leonard B. Saltz, Benjamin Musher +15 more

NRG-GI004/SWOG-S1610: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) study—A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps258

N/A

0DataRank · unranked

1 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +11 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps259

N/A

0DataRank · unranked

1 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +8 more

Alliance A022101: A pragmatic, randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: Evaluating Radiation, Ablation, and Surgery (ERASur).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3629

N/A

0DataRank · unranked

1 citations

Paul B. Romesser, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)

Research Square(2023)10.21203/rs.3.rs-3773522/v1

N/A

0DataRank · unranked

1 citations

Eric D. Miller, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +13 more

NRG GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps260

N/A

0DataRank · unranked

0 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +10 more

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART SWOG 1609) in patients with refractory gallbladder cancer (cohort 48).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e16330

N/A

0DataRank · unranked

0 citations

Elizabeth Guadarrama, Young Kwang Chae, Chih‐Yi Liao, Anup Kasi, Grace R. Tarabay +12 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3625

N/A

0DataRank · unranked

0 citations

Greg Yothers, Scott Kopetz, Shannon L. Puhalla, Peter C. Lucas, Atif Iqbal +8 more

Effect of Eligibility Criteria on Patients’ Survival and Serious Adverse Events in Colorectal Cancer Drug Trials

medRxiv(2024)10.1101/2024.04.03.24305265

N/A

0DataRank · unranked

0 citations

Chang Wang, Aokun Chen, Xing He, Patrick Balian, Thomas J. George +4 more

Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation, ablation, and surgery (ERASur).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.tps3633

N/A

0DataRank · unranked

0 citations

Kathryn Hitchcock, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

GLP-1 RA Use and Survival Among Older Adults With Cancer and Type 2 Diabetes

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.21887

N/A

0DataRank · unranked

12 citations

Ying Lü, Hao Dai, Thomas J. George, Yi Guo, Jingchuan Guo +2 more

Mechanical Modulation, Physiological Roles, and Imaging Innovations of Intercellular Calcium Waves in Living Systems

Cancers(2025)10.3390/cancers17111851

N/A

0DataRank · unranked

6 citations

Yuning Feng, Chenyu Liang, Angela Liang, Hezhong Tian, Om Narayan +14 more

Assessing perceptions of patient-centered care during telehealth visits provided via rural county Extension offices: an implementation pilot study

mHealth(2025)10.21037/mhealth-24-47

N/A

0DataRank · unranked

4 citations

Valeria Westring, Anna Hooks, C Morand, Tyler Jordan-Black, William T. Donahoo +8 more

Drugit: crowd-sourcing molecular design of non-peptidic VHL binders

Nature Communications(2025)10.1038/s41467-025-58406-0

N/A

0DataRank · unranked

2 citations

Christian A. Smethurst, Yvonne Westermaier, Moriz Mayer, Peter Greb, Roland Kousek +57 more

A real-world cohort study of immune-related adverse events in patients receiving immune checkpoint inhibitors

medRxiv(2025)10.1101/2025.01.24.25321082

N/A

0DataRank · unranked

2 citations

Yi Guo, Aik Choon Tan, Lili Zhao, Xu Shi, Yong Chen +7 more

Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation, ablation, and surgery (ERASur).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.tps3634

N/A

0DataRank · unranked

0 citations

Kathryn Hitchcock, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

Clinical Trial Generalizability Assessment in the Big Data Era: A Review

Clinical and Translational Science(2020)10.1111/cts.12764

N/A

0DataRank · unranked

136 citations

Xiang D. Tang, Xi Yang, Yi Guo, Thomas J. George, Neil Charness +4 more

Trials in progress: Alliance A022104/NRG-GI010—A randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer (LARC; the Janus Rectal Cancer trial).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.tps3650

N/A

0DataRank · unranked

0 citations

Qian Shi, Arvind Dasari, Julio García‐Aguilar, Hanna K. Sanoff, Thomas J. George +15 more

Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes

Cancer Medicine(2020)10.1002/cam4.3042

N/A

0DataRank · unranked

20 citations

Patrick W. Underwood, Kai Yang, Kelly M. Herremans, Miles E. Cameron, Srikar Chamala +6 more

Incorporation of lateral microfiltration with immunoaffinity for enhancing the capture efficiency of rare cells

Scientific Reports(2020)10.1038/s41598-020-71041-7

N/A

0DataRank · unranked

29 citations

Jacob Amontree, Jose I. Varillas, Jinling Zhang, Thomas J. George, Z. Hugh Fan +1 more

Tailoring virtual human‐delivered interventions: A digital intervention promoting colorectal cancer screening for Black women

Psycho-Oncology(2020)10.1002/pon.5538

N/A

0DataRank · unranked

24 citations

Danyell Wilson-Howard, Lauren Griffin, Fatemeh Tavassoli, Mohan Zalake, Benjamin Lok +5 more

NRG-GI005 (COBRA): Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.tps261

N/A

0DataRank · unranked

17 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +7 more

Using Real-World Data to Rationalize Clinical Trials Eligibility Criteria Design: A Case Study of Alzheimer’s Disease Trials

medRxiv(2020)10.1101/2020.08.02.20166629

N/A

0DataRank · unranked

14 citations

Yi Guo, Zhe He, Hansi Zhang, Thomas J. George, Jiang Bian +1 more

A randomized phase III study of mFOLFOX6/bevacizumab combination chemotherapy with or without atezolizumab or atezolizumab monotherapy in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) study (NRG-GI004/SWOG-S1610).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.tps260

N/A

0DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps4121

N/A

0DataRank · unranked

4 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +7 more

Clinicopathological and molecular biological characteristics of early-onset stage II/III colorectal adenocarcinoma: An analysis of 25 studies with 47,184 patients (pts) in the adjuvant colon cancer end points (ACCENT) database.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4099

N/A

0DataRank · unranked

1 citations

Jesse G. Dixon, Hiral D. Parekh, Steven R. Alberts, Greg Yothers, Carmen J. Allegra +15 more

Exploring the Feasibility of Using Real-World Data from a Large Clinical Data Research Network to Simulate Clinical Trials of Alzheimer’s Disease

medRxiv(2020)10.1101/2020.08.16.20167577

Top 100%

0DataRank

Top 100%0 citations

Hansi Zhang, Yi Guo, Thomas J. George, Mattia Prosperi, William R. Hogan +5 more

Extracting social determinants of health from electronic health records using natural language processing: a systematic review

Journal of the American Medical Informatics Association(2021)10.1093/jamia/ocab170

N/A

0DataRank · unranked

240 citations

Mohit Sharma, Veer Vekaria, Prakash Adekkanattu, Olga V. Patterson, Benjamin Scott Glicksberg +17 more

Key changes to improve social presence of a virtual health assistant promoting colorectal cancer screening informed by a technology acceptance model

BMC Medical Informatics and Decision Making(2021)10.1186/s12911-021-01549-z

N/A

0DataRank · unranked

29 citations

Danyell Wilson-Howard, Mohan Zalake, Fatemeh Tavassoli, Benjamin Lok, François Modave +5 more

The association between cognitive impairment and breast and colorectal cancer screening utilization

BMC Cancer(2021)10.1186/s12885-021-08321-6

N/A

0DataRank · unranked

16 citations

Jiang Bian, Thomas J. George, Karen Daily, Dongyu Zhang, Dejana Braithwaite +2 more

Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab187

N/A

0DataRank · unranked

16 citations

Mohamed E. Salem, Jesse G. Dixon, Zhaohui Jin, Romain Cohen, Aimery DeGramont +16 more

NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)—Pembrolizumab experimental arm (EA) primary results.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.8

N/A

0DataRank · unranked

32 citations

Greg Yothers, Theodore S. Hong, Marcia M. Russell, Y. Nancy You, William Parker +10 more

Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)—NRG-GI004/SWOG-S1610.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps3618

N/A

0DataRank · unranked

7 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer:NRG-GI005 (COBRA).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.tps148

N/A

0DataRank · unranked

5 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +7 more

Phase II/III study of Circulating tumOr DNA as a predictive BiomaRker in Adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps3622

N/A

0DataRank · unranked

2 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +7 more

Associations of Overall Survival with Geriatric Nutritional Risk Index in Patients with Advanced Pancreatic Cancer

Nutrients(2022)10.3390/nu14183800

N/A

0DataRank · unranked

26 citations

Thomas J. George, Bo Han, Saunjoo L. Yoon, Christina Grinstead

Can virtual human clinicians help close the gap in colorectal cancer screening for rural adults in the United States? The influence of rural identity on perceptions of virtual human clinicians

Preventive Medicine Reports(2022)10.1016/j.pmedr.2022.102034

N/A

0DataRank · unranked

19 citations

Kyle Duke, Elizabeth Flood‐Grady, Melissa J. Vilaro, Rashi Ghosh, Naomi D. Parker +7 more

Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma

Biosensors(2022)10.3390/bios12040206

N/A

0DataRank · unranked

10 citations

Minh-Chau N. Le, Benjamin Burgess, Zhijie Yang, Yu Zhao, Youxiang Wang +3 more

Telehealth and racial disparities in colorectal cancer screening: A pilot study of how virtual clinician characteristics influence screening intentions

Journal of Clinical and Translational Science(2022)10.1017/cts.2022.386

N/A

0DataRank · unranked

9 citations

Kyle Duke, Jordan M. Neil, Melissa J. Vilaro, Danyell Wilson-Howard, François Modave +8 more

NRG-GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps212

N/A

0DataRank · unranked

7 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +8 more

NRG-GI004/SWOG-S1610: Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study—A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps232

N/A

0DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

Thomas J. George

Indexed papers

Top data-sharing exemplar

Papers